Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
Journal.ie on MSN1d
'King Kong' of weight-loss drugs, Mounjaro, will be available in Ireland from next weekUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...
From the 17th of February this year, Mounjaro will be licenced for use as a treatment in Ireland for both type 2 diabetes and obesity. Maura Fay spoke to Dr Michael Crotty, clinical lead for ...
Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a big revenue increase Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound ...
The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...
GLP-1 drugs Mounjaro and Zepbound drive a big revenue increase for the drugmaker Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback